PIK-293

CAS No. 900185-01-5

PIK-293( PIK-293 | PIK 293 | PIK293 )

Catalog No. M17650 CAS No. 900185-01-5

PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 In Stock
5MG 110 In Stock
10MG 177 In Stock
25MG 312 In Stock
50MG 464 In Stock
100MG 662 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PIK-293
  • Note
    Research use only, not for human use.
  • Brief Description
    PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
  • Description
    PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PIK-293 | PIK 293 | PIK293
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    p110α| p110β| p110γ| p110δ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    900185-01-5
  • Formula Weight
    397.43
  • Molecular Formula
    C22H19N7O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (125.81 mM)
  • SMILES
    Cc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(cn1)c(ncn2)N
  • Chemical Name
    2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Knight ZA et al. Cell, 2006, 125(4), 733-747.
molnova catalog
related products
  • CC-401 hydrochloride

    CC-401 hydrochloride is a potent, selective, ATP-competitive pan-JNK inhibitor with Ki of 25-50 nM.

  • JNK-IN-8

    JNK-IN-8 is a potent, selective, pan-JNK inhibitor with IC50 of 4.7 nM, 18.7 nM and 1 nM for JNK1, JNK2 and JNK3, respectively.

  • J30-8

    J30-8 is a subtype-selective and potent JNK3 inhibitor (IC50: 40 nM) with neuroprotective activity for the study of neurodegenerative diseases such as Alzheimer's disease.